Sep 21, 2026 9 0
Uploaded by Eliana
Favorite
Share
More Options
17
Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers_Page 1

Open in WPS to view all 17 pages